{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T09:04:45Z","timestamp":1716800685386},"reference-count":6,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,25]],"date-time":"2014-04-25T00:00:00Z","timestamp":1398384000000},"content-version":"vor","delay-in-days":3342,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atenci\u00f3n Primaria"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1157\/13072596","type":"journal-article","created":{"date-parts":[[2005,3,14]],"date-time":"2005-03-14T13:11:19Z","timestamp":1110805879000},"page":"219-220","source":"Crossref","is-referenced-by-count":2,"title":["Respuesta de la industria farmac\u00e9utica ante una consulta espec\u00edfica"],"prefix":"10.1016","volume":"35","author":[{"given":"I.","family":"V\u00e1zquez G\u00f3mez","sequence":"first","affiliation":[]},{"given":"F.","family":"Fern\u00e1ndez-Llimos","sequence":"additional","affiliation":[]},{"given":"M.A.","family":"Gastelurrutia","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1157\/13072596_bib1","series-title":"Uso racional de medicamentos; Informe de la Conferencia de Expertos de Nairobi","year":"1986"},{"key":"10.1157\/13072596_bib2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1345\/aph.18421","article-title":"Product monographs supplied by drug manufacturers to community pharmacists in Spain","volume":"34","author":"Fern\u00e1ndez-Llim\u00f3s","year":"2000","journal-title":"Ann Pharmacother"},{"key":"10.1157\/13072596_bib3","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1001\/jama.1995.03520400066047","article-title":"The accuracy of drug information from pharmaceutical sales representatives","volume":"273","author":"Ziegler","year":"1995","journal-title":"JAMA"},{"key":"10.1157\/13072596_bib4","first-page":"76","article-title":"Perfil profesional y de formaci\u00f3n de los visitadores m\u00e9dicos de M\u00e1laga","volume":"4","author":"Bellido","year":"1994","journal-title":"Rev OFIL"},{"key":"10.1157\/13072596_bib5","first-page":"422","article-title":"An\u00e1lisis de la informaci\u00f3n sobre las condiciones de conservaci\u00f3n fuera del envase original de los medicamentos m\u00e1s prescritos","volume":"3","author":"Fajardo","year":"2001","journal-title":"Pharm Care Esp"},{"key":"10.1157\/13072596_bib6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/dtb.1994.32535","article-title":"Talking about drug treatments: Who should say what to whom? The second DTB symposium","volume":"32","author":"Anon","year":"1994","journal-title":"Drug Ther Bull"}],"container-title":["Atenci\u00f3n Primaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656705703255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656705703255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T22:50:18Z","timestamp":1548629418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0212656705703255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":6,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0212656705703255"],"URL":"https:\/\/doi.org\/10.1157\/13072596","relation":{},"ISSN":["0212-6567"],"issn-type":[{"value":"0212-6567","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}